Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model.

Availability of an ultra-short-course drug regimen capable of curing patients with tuberculosis in 2 to 3 mo would significantly improve global control efforts. Because immediate prospects for novel treatment-shortening drugs remain uncertain, we examined whether better use of existing drugs could s...

Full description

Bibliographic Details
Main Authors: Ian M Rosenthal, Ming Zhang, Kathy N Williams, Charles A Peloquin, Sandeep Tyagi, Andrew A Vernon, William R Bishai, Richard E Chaisson, Jacques H Grosset, Eric L Nuermberger
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2007-12-01
Series:PLoS Medicine
Online Access:http://europepmc.org/articles/PMC2140085?pdf=render